World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
28493
World Ranking
13624
National Ranking
6923

Overview

Guido Dalbagni is affiliated with Memorial Sloan Kettering Cancer Center in the United States and has an extensive research portfolio primarily focused on medicine, with a particular emphasis on surgery, urology, and oncology. Their work spans both clinical and molecular investigations, incorporating subfields such as molecular biology and pulmonary and respiratory medicine.

Their research covers key topics related to bladder and urothelial cancer treatments, urinary and genital oncology studies, and urological disorders and treatments. Additional focal points include cancer immunotherapy and biomarkers, epigenetics and DNA methylation, esophageal cancer research and treatment, and studies on multiple and secondary primary cancers.

Dalbagni has contributed significantly to the literature, with notable frequent publication venues including:

  • The Journal of Urology
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Urologic Oncology Seminars and Original Investigations
  • European Urology

Frequent collaborators in their research include Bernard H. Bochner, Eugene J. Pietzak, S. Machele Donat, Hikmat Al-Ahmadie, and Harry W. Herr, reflecting sustained partnerships in advancing urological and oncological research.

Among selected recent papers, the following stand out:

  • Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma, 2023, Journal of Clinical Oncology
  • Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort, 2021, European Urology
  • Goal-directed versus Standard Fluid Therapy to Decrease Ileus after Open Radical Cystectomy, 2020, Anesthesiology
  • The impact of fluid optimisation before induction of anaesthesia on hypotension after induction, 2020, Anaesthesia
  • The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers, 2021, Advances in Anatomic Pathology

Dalbagni's body of work demonstrates a multidisciplinary approach integrating clinical treatment strategies with underlying molecular and immunologic mechanisms, contributing to improving knowledge in bladder and urothelial cancer management and related oncologic specialties.

Best Publications

  • Epidemiology and risk factors of urothelial bladder cancer

    Maximilian Burger;James W.F. Catto;Guido Dalbagni;H. Barton Grossman

  • Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

    Ahmad Shabsigh;Ruslan Korets;Kinjal C. Vora;Christine M. Brooks

  • Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update

    M. Craig Hall;Sam S. Chang;Guido Dalbagni;Raj Som Pruthi

  • Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.

    Harry W. Herr;Bernard H. Bochner;Guido Dalbagni;S. Machele Donat

  • Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease Progression

    Alvaro S. Sarkis;Guido Dalbagni;Carlos Cordon-Cardo;Zuo-Feng Zhang

  • Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

    Bernard H. Bochner;Guido Dalbagni;Daniel D. Sjoberg;Jonathan Silberstein;Jonathan Silberstein

  • Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.

    Bernard H. Bochner;Guido Dalbagni;Michael W. Kattan;Paul Fearn

  • CYSTECTOMY FOR BLADDER CANCER: A CONTEMPORARY SERIES

    Guido Dalbagni;Elizabeth Genega;Mia Hashibe;Zuo-Feng Zhang

  • Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder Cancer

    Carlos Cordon-Cardo;David Wartinger;Daniel Petrylak;Guido Dalbagni

  • Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.

    Atreya Dash;Matthew D. Galsky;Andrew J. Vickers;Angel M. Serio

  • Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer

    Theresa M. Koppie;Angel M. Serio;Andrew J. Vickers;Kinjal Vora

  • Urinary diversion after radical cystectomy for bladder cancer: Options, patient selection, and outcomes

    Richard K. Lee;Hassan Abol-Enein;Walter Artibani;Bernard Bochner

  • Genetic alterations in bladder cancer

    G. Dalbagni;J. Presti;W.R. Fair;V. Reuter

  • Phase I Trial of Intravesical Gemcitabine in Bacillus Calmette-Guérin–Refractory Transitional-Cell Carcinoma of the Bladder

    Guido Dalbagni;Paul Russo;Joel Sheinfeld;Madhu Mazumdar

  • Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.

    Eugene J. Pietzak;Aditya Bagrodia;Eugene K. Cha;Esther N. Drill

  • Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center Experience

    S. Machele Donat;Ahmad Shabsigh;Caroline Savage;Angel M. Cronin

  • p53 Mutations in human bladder cancer : genotypic versus phenotypic patterns

    Carlos Cordon-Cardo;Guido Dalbagni;Guillermo T. Saez;Maria R. Oliva

  • A Role for Neoadjuvant Gemcitabine Plus Cisplatin in Muscle-Invasive Urothelial Carcinoma of the Bladder: A Retrospective Experience

    Atreya Dash;Atreya Dash;Joseph A. Pettus;Joseph A. Pettus;Harry W. Herr;Harry W. Herr;Bernard H. Bochner;Bernard H. Bochner

  • Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?

    Theresa M. Koppie;Andrew J. Vickers;Kinjal Vora;Guido Dalbagni

  • Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.

    H.W Herr;B.H Bochner;G Dalbagni;S.M Donat

Frequent Co-Authors

Bernard H. Bochner
Bernard H. Bochner Memorial Sloan Kettering Cancer Center
Harry W. Herr
Harry W. Herr Memorial Sloan Kettering Cancer Center
Dean F. Bajorin
Dean F. Bajorin Memorial Sloan Kettering Cancer Center
Jonathan E. Rosenberg
Jonathan E. Rosenberg Memorial Sloan Kettering Cancer Center
Hikmat Al-Ahmadie
Hikmat Al-Ahmadie Memorial Sloan Kettering Cancer Center
David B. Solit
David B. Solit Memorial Sloan Kettering Cancer Center
Victor E. Reuter
Victor E. Reuter Memorial Sloan Kettering Cancer Center
Michael F. Berger
Michael F. Berger Memorial Sloan Kettering Cancer Center
Paul Russo
Paul Russo Memorial Sloan Kettering Cancer Center
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always have to start with medical school. There are several related online degrees and career pathways worth considering, many of which offer flexible and affordable learning options.

For those interested in administrative roles, affordable medical billing and coding programs are a practical choice. These courses prepare you for vital behind-the-scenes work in healthcare and can often be completed quickly.

Nursing remains a popular path, with multiple degree options available. If your goal is a direct-entry route, researching what is the cheapest online college for nursing? can help you find programs that fit your budget. Advanced roles, such as nurse practitioner, are accessible through affordable np programs that blend clinical training with online coursework.

For those aiming for leadership, research, or academic careers, there are opportunities to earn an online phd nursing. These programs allow nurses to reach the highest levels of expertise without sacrificing their professional or personal commitments.

Best Scientists Citing Guido Dalbagni

Trending Scientists